ABSTRACT
Preclinical model systems to study multiple features of the papillomavirus life cycle have greatly aided our understanding of Human Papillomavirus (HPV) biology, disease progression and treatments. The challenge to studying HPV in hosts is that HPV along with most PVs are both species and tissue restricted. Thus, fundamental properties of HPV viral proteins can be assessed in specialized cell culture systems but host responses that involve innate immunity and host restriction factors requires preclinical surrogate models. Fortunately, there are several well-characterized and new animal models of papillomavirus infections that are available to the PV research community. Old models that continue to have value include canine, bovine and rabbit PV models and new rodent models are in place to better assess host-virus interactions. Questions arise as to the strengths and weaknesses of animal PV models for HPV disease and how accurately these preclinical models predict malignant progression, vaccine efficacy and therapeutic control of HPV-associated disease. In this review, we examine current preclinical models and highlight the strengths and weaknesses of the various models as well as provide an update on new opportunities to study the numerous unknowns that persist in the HPV research field.
Subject(s)
Bovine papillomavirus 1/immunology , Cottontail rabbit papillomavirus/immunology , Disease Models, Animal , Lambdapapillomavirus/immunology , Papillomaviridae/immunology , Animals , Bovine papillomavirus 1/genetics , Bovine papillomavirus 1/growth & development , Bovine papillomavirus 1/pathogenicity , Cattle , Cottontail rabbit papillomavirus/genetics , Cottontail rabbit papillomavirus/growth & development , Cottontail rabbit papillomavirus/pathogenicity , Dogs , Female , Humans , Lambdapapillomavirus/genetics , Lambdapapillomavirus/growth & development , Lambdapapillomavirus/pathogenicity , Mice , Papillomaviridae/genetics , Papillomaviridae/growth & development , Papillomaviridae/pathogenicity , Papillomavirus Infections/immunology , Papillomavirus Infections/pathology , Papillomavirus Infections/prevention & control , Papillomavirus Infections/virology , Papillomavirus Vaccines/administration & dosage , Papillomavirus Vaccines/biosynthesis , Primates/virology , Rabbits , Rats , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Skin Neoplasms/prevention & control , Skin Neoplasms/virology , Uterine Cervical Neoplasms/immunology , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/prevention & control , Uterine Cervical Neoplasms/virologyABSTRACT
Papillomavirus DNA replication occurs in the nucleus of infected cells and requires the viral E1 protein, which enters the nuclei of host epithelial cells and carries out enzymatic functions required for the initiation of viral DNA replication. In this study, we investigated the pathway and regulation of the nuclear import of the E1 protein from bovine papillomavirus type 1 (BPV1). Using an in vitro binding assay, we determined that the E1 protein interacted with importins alpha3, alpha4, and alpha5 via its nuclear localization signal (NLS) sequence. In agreement with this result, purified E1 protein was effectively imported into the nucleus of digitonin-permeabilized HeLa cells after incubation with importin alpha3, alpha4, or alpha5 and other necessary import factors. We also observed that in vitro binding of E1 protein to all three alpha importins was significantly decreased by the introduction of pseudophosphorylation mutations in the NLS region. Consistent with the binding defect, pseudophosphorylated E1 protein failed to enter the nucleus of digitonin-permeabilized HeLa cells in vitro. Likewise, the pseudophosphorylation mutant showed aberrant intracellular localization in vivo and accumulated primarily on the nuclear envelope in transfected HeLa cells, while the corresponding alanine replacement mutant displayed the same cellular location pattern as wild-type E1 protein. Collectively, our data demonstrate that BPV1 E1 protein can be transported into the nucleus by more than one importin alpha and suggest that E1 phosphorylation by host cell kinases plays a regulatory role in modulating E1 nucleocytoplasmic localization. This phosphoregulation of nuclear E1 protein uptake may contribute to the coordination of viral replication with keratinocyte proliferation and differentiation.
Subject(s)
Bovine papillomavirus 1/genetics , Cell Nucleus/metabolism , DNA-Binding Proteins/metabolism , Nuclear Localization Signals/genetics , Viral Proteins/metabolism , alpha Karyopherins/metabolism , Active Transport, Cell Nucleus , Animals , Bovine papillomavirus 1/growth & development , Cattle , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Gene Expression Regulation, Viral , HeLa Cells , Humans , Phosphorylation , Transfection , Viral Proteins/genetics , Viral Proteins/isolation & purification , alpha Karyopherins/analysisABSTRACT
Previous studies have suggested that most papillomaviruses enter the host cell via clathrin-dependent receptor-mediated endocytosis but have not addressed later steps in viral entry. To examine these events, we followed the localization of L2 and packaged DNA after entry of infectious virions or L1/L2 pseudovirions. Confocal microscopic analyses of HeLa cells showed a time-dependent uncoating of capsids in cytoplasmic vesicles and the accumulation of both L2 and viral DNA at distinct nuclear domains identified as nuclear domain 10 (ND10). Both L2 and the pseudogenome had a punctate distribution and localized to ND10 in promyelocytic leukemia protein (PML)-expressing cells, whereas L2 had a diffuse nuclear distribution in PML-/- cells. The number of pseudovirus-infected cells was an order of magnitude higher in the PML+ cells compared with the PML-/- cells, and viral genome transcription after infection with authentic bovine papillomavirus virions was similarly elevated in PML+ cells. The results identify a role for PML in the enhancement of viral infectivity in the early part of the life cycle. We propose a model in which L2 chaperones the viral genome to ND10 to efficiently initiate viral transcription.
Subject(s)
Bovine papillomavirus 1/physiology , Neoplasm Proteins/biosynthesis , Nuclear Proteins/biosynthesis , Papillomavirus Infections/metabolism , Transcription Factors/biosynthesis , Animals , Bovine papillomavirus 1/growth & development , Bovine papillomavirus 1/pathogenicity , Capsid Proteins/genetics , Capsid Proteins/metabolism , Cattle , Cell Nucleus/metabolism , Cell Nucleus/virology , DNA, Viral/genetics , DNA, Viral/metabolism , Gene Expression , HeLa Cells , Humans , Mice , Microscopy, Confocal , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Promyelocytic Leukemia Protein , Pseudogenes/physiology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Transduction, Genetic , Tumor Suppressor Proteins , Zinc FingersABSTRACT
Although the papillomavirus structural proteins, L1 and L2, can spontaneously coassemble to form virus-like particles, currently available methods for production of L1/L2 particles capable of transducing reporter plasmids into mammalian cells are technically demanding and relatively low-yield. In this report, we describe a simple 293 cell transfection method for efficient intracellular production of papillomaviral-based gene transfer vectors carrying reporter plasmids. Using bovine papillomavirus type 1 (BPV1) and human papillomavirus type 16 as model papillomaviruses, we have developed a system for producing papillomaviral vector stocks with titers of several billion transducing units per milliliter. Production of these vectors requires both L1 and L2, and transduction can be prevented by papillomavirus-neutralizing antibodies. The stocks can be purified by an iodixanol (OptiPrep) gradient centrifugation procedure that is substantially more effective than standard cesium chloride gradient purification. Although earlier data had suggested a potential role for the viral early protein E2, we found that E2 protein expression did not enhance the intracellular production of BPV1 vectors. It was also possible to encapsidate reporter plasmids devoid of BPV1 DNA sequences. BPV1 vector production efficiency was significantly influenced by the size of the target plasmid being packaged. Use of 6-kb target plasmids resulted in BPV1 vector yields that were higher than those with target plasmids closer to the native 7.9-kb size of papillomavirus genomes. The results suggest that the intracellular assembly of papillomavirus structural proteins around heterologous reporter plasmids is surprisingly promiscuous and may be driven primarily by a size discrimination mechanism.
Subject(s)
Bovine papillomavirus 1/metabolism , Genetic Vectors , Papillomaviridae/metabolism , Virus Assembly , Animals , Antibodies, Viral/immunology , Bovine papillomavirus 1/genetics , Bovine papillomavirus 1/growth & development , Capsid Proteins/genetics , Capsid Proteins/metabolism , Cattle , Cell Line , Humans , Molecular Sequence Data , Neutralization Tests , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/metabolism , Papillomaviridae/genetics , Papillomaviridae/growth & development , Papillomaviridae/immunology , Plasmids , Sequence Analysis, DNA , TransfectionABSTRACT
A female 8-month-old Simmental calf was presented with a history of a gradually enlarging mass in the ventral abdominal skin since 4 months of age. The mass was well circumscribed, lightly pigmented, and rough surfaced with many fine fissures and was attached to the skin by a relatively broad pedicle. On cut section, there was a border between the reddish-black stroma and overlying epithelium, including hemorrhagic foci of variable sizes. Histologically, the tumor was papillomatous with angiokeratomatous features and irregular hyperplasia with epidermal rete ridges and dilated vascular channels filled with blood in the superficial dermis. In the epidermis, orthokeratotic hyperkeratosis, variably sized keratohyalin granules, and many koilocytes, some of which had papillomavirus (PV) genus-specific structural antigen-positive nuclei, were also observed. Cells lining the dilated vascular spaces were positive for vimentin and alpha-smooth muscle actin but negative for factor VIII-related antigen, desmin, and PV. The lesion was regarded as an angiokeratomatous papilloma and was similar to other angiomatous lesions.
Subject(s)
Angiokeratoma/veterinary , Bovine papillomavirus 1/growth & development , Cattle Diseases/pathology , Cattle Diseases/virology , Papillomavirus Infections/veterinary , Skin Neoplasms/veterinary , Tumor Virus Infections/veterinary , Angiokeratoma/pathology , Angiokeratoma/surgery , Angiokeratoma/virology , Animals , Cattle , Female , Immunohistochemistry/veterinary , Papillomavirus Infections/pathology , Papillomavirus Infections/surgery , Papillomavirus Infections/virology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Skin Neoplasms/virology , Tumor Virus Infections/pathology , Tumor Virus Infections/surgery , Tumor Virus Infections/virologyABSTRACT
OBJECTIVE: To determine the incidence of bovine papillomavirus (BPV) type 1 or 2 in sarcoids and other samples of cutaneous tissues collected from horses in the western United States. ANIMALS: 55 horses with sarcoids and 12 horses without sarcoids. PROCEDURE: Tissue samples (tumor and normal skin from horses with sarcoids and normal skin, papillomas, and nonsarcoid cutaneous neoplasms from horses without sarcoids) were collected. Tissue samples were analyzed for BPV-1 or -2 DNA, using a polymerase chain reaction (PCR) and restriction fragment length polymorphism. The PCR products from 7 sarcoid-affected horses were sequenced to evaluate percentage homology with expected sequences for BPV-1 or-2. RESULTS: Most (94/96, 98%) sarcoids contained BPV DNA. Sixty-two percent of the tumors examined had restriction enzyme patterns consistent with BPV-2. Thirty-one of 49 (63%) samples of normal skin obtained from horses with sarcoids contained BPV DNA. All samples subsequently sequenced had 100% homology with the expected sequences for the specific viral type. All tissues from healthy horses, nonsarcoid neoplasms, and papillomas were negative for BPV DNA. CONCLUSIONS AND CLINICAL RELEVANCE: Bovine papillomaviral DNA was detected in essentially all sarcoids examined. There appears to be regional variation in the prevalence of viral types in these tumors. The fact that we detected viral DNA in normal skin samples from horses with sarcoids suggests the possibility of a latent viral phase. Viral latency may be 1 explanation for the high rate of recurrence following surgical excision of sarcoids.
Subject(s)
Bovine papillomavirus 1/genetics , Horse Diseases/virology , Papillomavirus Infections/veterinary , Sarcoidosis/veterinary , Skin Neoplasms/veterinary , Tumor Virus Infections/veterinary , Animals , Bovine papillomavirus 1/growth & development , Cattle , DNA, Viral/genetics , DNA, Viral/isolation & purification , Histocytochemistry , Horse Diseases/pathology , Horses , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Polymerase Chain Reaction/veterinary , Polymorphism, Restriction Fragment Length , Sarcoidosis/pathology , Sarcoidosis/virology , Skin Neoplasms/pathology , Skin Neoplasms/virology , Tumor Virus Infections/pathology , Tumor Virus Infections/virology , United StatesABSTRACT
This paper describes the characterization of cell lines that stably maintain linear copies of bovine papillomavirus 1 (BPV-1). Cell lines were generated by liposome-mediated transfection of BamH1-linearized virus into C127I cells. Two transfectants with morphologies differing from each other and from that of the parental cell line were characterized. Southern blots indicated that they contain ten to twelve copies of the BPV-1 genome per cell and that the predominant species in both cell lines are linear BPV-1 episomes. One to two copies per genome of a slow migrating species are also present. Both BPV-1 species found in these cells are sensitive to BAL31 digestion. Viral chromosomal ends were amplified by anchored PCR, cloned and sequenced. Our results indicate that no major rearrangements have occurred in the sequence flanking the BamH1 site where the virus used for transfection was linearized. No circular BPV-1 molecules were detected by PCR. The slow migrating species may serve as templates for replication for the linear forms by a yet unidentified mechanism.
Subject(s)
Bovine papillomavirus 1/growth & development , Genome, Viral , Animals , Blotting, Southern , Bovine papillomavirus 1/genetics , Cell Transformation, Viral , DNA, Viral/biosynthesis , DNA, Viral/chemistry , Exonucleases/chemistry , Mice , Microscopy, Phase-Contrast , Polymerase Chain Reaction , Transfection , Tumor Cells, CulturedABSTRACT
The green fluorescent protein (GFP) from the jellyfish Aequorea victoria has attracted widespread interest since it was demonstrated to be fluorescent in vivo when expressed in other organisms. In order to investigate papillomavirus life cycle which hampered by the unavailability of conventional cell culture system, we constructed a chimeric bovine papillomavirus (BPV) type 1 virus-like particles (VLPs) containing GFP. It was found that fluorescent VLPs could be assembled from L2 protein in which GFP is inserted into the N-terminal region of L2 (aa 88). The fluorescent VLPs could also be assembled from a GFP/L2 fusion protein in which part of the L2 sequence had been deleted. In vitro, fluorescent VLPs could bind to CV-1 cells, and this VLP/cell interaction could be analyzed by FACS assay. These results demonstrated that GFP could incorporate into BPV1 VLPs without disruption of the VLP structure. Fluorescent VLPs might be a useful tool for study of papillomavirus virus/cell interaction.
Subject(s)
Bovine papillomavirus 1/physiology , Luminescent Proteins/genetics , Virion/physiology , Baculoviridae/genetics , Bovine papillomavirus 1/growth & development , Capsid Proteins/physiology , Cell Line , Green Fluorescent Proteins , Luminescent Proteins/physiology , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/genetics , Virion/genetics , Virus AssemblyABSTRACT
We have used immunofluorescent staining and confocal microscopy to examine the subcellular localization of structural and nonstructural bovine papillomavirus (BPV) proteins in cultured cells that produce infectious virions. When expressed separately, L1, the major capsid protein, showed a diffuse nuclear distribution while L2, the minor capsid protein, was found to localize to punctate nuclear regions identified as promonocytic leukemia protein (PML) oncogenic domains (PODs). Coexpression of L1 and L2 induced a relocation of L1 into the PODs, leading to the colocalization of L1 and L2. The effect of L2 expression on the distribution of the nonstructural viral proteins E1 and E2, which are required for maintenance of the genome and viral DNA synthesis, was also examined. The localization of the E1 protein was unaffected by L2 expression. However, the pattern of anti-E2 staining was dramatically altered in L2-expressing cells. Similar to L1, E2 was shifted from a dispersed nuclear locality into the PODs and colocalized with L2. The recruitment of full-length E2 by L2 occurred in the absence of other viral components. L2 was shown previously to be essential for the generation of infectious BPV. Our present results provide evidence for a role for L2 in the organization of virion components by recruiting them to a distinct nuclear domain. This L2-dependent colocalization probably serves as a mechanism to promote the assembly of papillomaviruses either by increasing the local concentration of virion constituents or by providing the physical architecture necessary for efficient packaging and assembly. The data also suggest a role for a nonstructural viral protein, E2, in virion assembly, specifically the recruitment of the viral genome to the sites of assembly, through its high-affinity interaction with specific sequences in the viral DNA.
Subject(s)
Bovine papillomavirus 1/growth & development , Bovine papillomavirus 1/metabolism , Capsid Proteins , Capsid/metabolism , DNA-Binding Proteins/metabolism , Neoplasm Proteins , Nuclear Proteins , Transcription Factors/metabolism , Viral Proteins/metabolism , Animals , Bovine papillomavirus 1/genetics , Capsid/genetics , Cattle , Cell Line , Cell Nucleus/metabolism , Cell Nucleus/virology , Cricetinae , DNA-Binding Proteins/genetics , Fluorescent Antibody Technique , Genome, Viral , Models, Biological , Oncogenes , Transcription Factors/genetics , Tumor Suppressor Proteins , Viral Proteins/geneticsABSTRACT
There is strong epidemiologic evidence for sexual transmission of high-risk genital human papillomavirus (HPV) types. However, it is unclear if infection may also be transmitted indirectly via fomites. To assess this possibility, the in vitro infectivity after desiccation was compared for pseudotype HPV-16 virions, a model for high-risk type genital HPV, and bovine papillomavirus type 1 (BPV-1), a papillomavirus known to be transmitted via fomites. The 2 viruses had similar resistance to desiccation in cell extracts, retaining approximately 100%, 50%, and 30% of infectivity when dehydrated for 1, 3, and 7 days, respectively, at room temperature. Pseudotype HPV-16 and BPV in cell extracts were completely inactivated by autoclave treatment and susceptible to 70% ethanol but were resistant to EDTA or incubation at 56 degrees C for 1 h. The data suggest that further study of nonsexual spread of high-risk genital HPV via fomites is warranted.
Subject(s)
Bovine papillomavirus 1/growth & development , Desiccation , Papillomaviridae/growth & development , Papillomavirus Infections/transmission , Tumor Virus Infections/transmission , Bovine papillomavirus 1/immunology , Bovine papillomavirus 1/pathogenicity , Cells, Cultured , Edetic Acid/pharmacology , Ethanol/pharmacology , Heating/adverse effects , Neutralization Tests , Papillomaviridae/immunology , Papillomaviridae/pathogenicity , Time FactorsABSTRACT
Bovine papillomavirus (BPV) DNA has been reported to restrict its own replication and that of the lytic simian virus 40 (SV40) origin to one initiation event per molecule per S phase, which suggests BPV DNA replication as a model for cellular chromosome replication. Suppression of the SV40 origin required two cis-acting BPV sequences (NCOR-1 and -2) and one trans-acting BPV protein. The results presented in this paper confirm the presence of two NCOR sequences in the BPV genome that can suppress polyomavirus (PyV) as well as SV40 origin-dependent DNA replication as much as 40-fold. However, in contrast to results of previous studies on SV40, most of the suppression of the PyV origin was due to NCOR-1, a 512-bp sequence that functioned independently of distance or orientation with respect to the PyV origin and that was not required for BPV DNA replication. Moreover, NCOR-1 alone or together with NCOR-2 did not restrict the ability of the PyV ori to reinitiate replication within a single S phase and did not require any BPV protein to exert suppression. Furthermore, NCOR-1 did not suppress BPV origin-dependent DNA replication except in the presence of PyV large tumor antigen (T-ag). Since NCOR-1 suppression of PyV origin activity also varied with T-ag concentration, suppression of origins by NCOR sequences appeared to require papovavirus T-ag. Therefore, it is unlikely that NCOR sequences are involved in regulating BPV DNA replication. When these results are taken together with those from other laboratories, BPV appears to be a slowly replicating version of papovaviruses rather than a model for origins of DNA replication in eukaryotic cell chromosomes.
Subject(s)
Bovine papillomavirus 1/growth & development , Bovine papillomavirus 1/genetics , DNA Replication/genetics , Regulatory Sequences, Nucleic Acid , Suppression, Genetic , Antigens, Viral, Tumor/pharmacology , DNA Mutational Analysis , DNA Replication/drug effects , DNA-Binding Proteins/metabolism , Electroporation , Papillomaviridae/immunology , Plasmids/genetics , Polyomaviridae , Polyomavirus/genetics , S Phase , Sequence Deletion , Viral Proteins/metabolismABSTRACT
We have previously observed that bovine papillomavirus type 1 (BPV-1) induces the appearance of five cellular proteins in C127 mouse fibroblasts, four of which appear to arise by altered processing of resident endoplasmic reticulum proteins. Studies of various cell lines revealed that expression of the 3' end of the BPV early region was sufficient for induction of these changes. To identify the BPV gene responsible, we have utilized the simian virus 40 (SV40)/BPV-1 recombinant virus Pava-1, which expresses the 3' end of the BPV early region behind an SV40 early promoter. C127 cells infected with Pava-1 for 48 h show the expected BPV-associated alterations, as do cells infected with Pava constructs mutated in the E5 or E2 genes. However, a mutation in the start codon of a previously ignored open reading frame extending from nucleotides 4013 to 4170 (E5B) eliminated the BPV-associated changes. Similar results were obtained with COS cells infected with the Pava mutants and C127 cells transformed by full-length mutated BPV. Despite its influence on the processing of cellular endoplasmic reticulum proteins, this mutation in E5B did not alter BPV-transforming efficiency or the ability of transformants to form colonies in soft agar. The E5B open reading frame encodes a hydrophobic 52-amino-acid polypeptide that shares structural similarities with HPV6 E5A and HPV16 E5. Speculations on a role for E5B in the viral life cycle are discussed.
Subject(s)
Bovine papillomavirus 1/genetics , Open Reading Frames/genetics , Protein Processing, Post-Translational , Viral Proteins/genetics , Amino Acid Sequence , Animals , Bovine papillomavirus 1/growth & development , Calcium-Binding Proteins/metabolism , Calreticulin , Cell Transformation, Viral , Cells, Cultured , Endoplasmic Reticulum/metabolism , Mice , Molecular Sequence Data , Mutagenesis , Protein Structure, Secondary , Recombinant Proteins/metabolism , Sequence Deletion , Viral Proteins/biosynthesis , Viral Proteins/metabolismABSTRACT
The 23-kDa protein encoded by the 5' segment of the E1 open reading frame of bovine papillomavirus type 1 (BPV1) was previously ascribed a negative regulatory function for the replication of viral plasmid DNA. However, results from recent functional and biochemical studies do not readily support this genetic assignment. Therefore, we have reassessed the role of this protein in papillomavirus DNA replication by using a mutant of BPV1 which is unable to express this E1 protein. This mutant viral DNA was found to replicate extrachromosomally with stability and copy number per cell similar to those of wild-type plasmid DNA. Thus, the absence of expression of the 23-kDa E1 protein did not lead to deregulated viral plasmid replication. We conclude that the 23-kDa E1 protein is nonessential for stable plasmid replication.
Subject(s)
Bovine papillomavirus 1/growth & development , DNA Replication/genetics , DNA, Viral/genetics , DNA-Binding Proteins/genetics , Plasmids , Viral Proteins/genetics , Amino Acid Sequence , Antibodies, Viral , Base Sequence , Bovine papillomavirus 1/genetics , Bovine papillomavirus 1/pathogenicity , DNA-Binding Proteins/immunology , Drug Resistance, Microbial , Gentamicins/pharmacology , Molecular Sequence Data , Precipitin Tests , RNA, Viral/genetics , Selection, Genetic , Serial Passage , Transfection , Viral Proteins/immunology , Virus ReplicationABSTRACT
Bovine papillomavirus type 1 (BPV-1) virions were produced in vitro using vaccinia virus (VV) recombinants expressing the BPV-1 L1 and L2 capsid proteins. Particles morphologically resembling papillomaviruses were observed in the nucleus of cells infected with a VV recombinant for the BPV-1 L1 protein, and greater numbers of similar particles were seen in the nuclei of cells infected with a VV double recombinant for L1 and L2. Virus-like particles (VLPs) assembled in cells infected with the VV double recombinant for BPV-1 L1 and L2, and not those assembled in cells infected with the VV recombinant for BPV-1 L1 alone, were able to package BPV-1 DNA. Transcription of the BPV-1 E1 viral open reading frame was observed after a mouse fibroblast cell line was exposed to VLPs produced using a BPV-1 L1/L2 VV recombinant in a cell line containing episomal BPV-1 DNA. E1 transcription was not observed when the VLPs were pre-incubated with antibodies to the capsid protein of BPV-1. This system should allow an in vitro approach to the definition of the BPV-1 cellular receptor.
Subject(s)
Bovine papillomavirus 1/ultrastructure , Animals , Base Sequence , Bovine papillomavirus 1/growth & development , Capsid/genetics , Capsid/metabolism , Cattle , Cloning, Molecular , In Vitro Techniques , Molecular Sequence Data , Oligodeoxyribonucleotides/chemistry , Recombinant Proteins/metabolism , Vaccinia virus , Virus ReplicationABSTRACT
Bovine papillomavirus (BPV) DNA replication occurs in the nucleus of infected cells. Most enzymatic activities are carried out by host cell proteins, with the viral E1 and E2 proteins required for the assembly of an initiation complex at the replication origin. In latently infected cells, viral DNA replication occurs in synchrony with the host cell chromosomes, maintaining a constant average copy number of BPV genomes per infected cell. By analyzing a series of mutants of the amino-terminal region of the E1 protein, we have identified the signal for transport of this protein to the cell nucleus. The E1 nuclear transport motif is highly conserved in the animal and human papillomaviruses and is encoded in a similar region in the related E1 genes. The signal is extended relative to the simple nuclear localization signals and contains two short amino acid sequences which contribute to nuclear transport, located between amino acids 85 and 108 of the BPV-1 E1 protein. Mutations in either basic region reduce nuclear transport of E1 protein and interfere with viral DNA replication. Mutations in both sequences simultaneously prevent any observable accumulation of the protein and reduce replication in transient assays to barely detectable levels. Surprisingly, these mutations had no effect on the ability of viral genomes to morphologically transform cells, although the plasmid DNA in the transformed cells was maintained at a very low copy number. Between these two basic amino acid blocks in the nuclear transport signal, at threonine 102, is a putative site for phosphorylation by the cell cycle regulated kinase p34cdc2. Utilizing an E1 protein purified from either a baculovirus vector system or Escherichia coli, we have shown that the E1 protein is a substrate for this kinase. An E1 gene mutant at threonine 102 encodes for a protein which is no longer a substrate for the p34cdc2 kinase. Mutation of this threonine to isoleucine had no observable effect on either nuclear localization of E1 or DNA replication of the intact viral genome.
Subject(s)
Bovine papillomavirus 1/genetics , CDC2 Protein Kinase/metabolism , Cell Compartmentation , DNA-Binding Proteins/metabolism , Protein Sorting Signals/genetics , Viral Proteins/metabolism , Amino Acid Sequence , Animals , Biological Transport , Bovine papillomavirus 1/growth & development , Cell Line , Cell Nucleus/metabolism , DNA Mutational Analysis , DNA Replication , DNA, Viral/biosynthesis , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Fluorescent Antibody Technique , Molecular Sequence Data , Phosphorylation , Phosphoserine/metabolism , Phosphothreonine/metabolism , Sequence Homology, Amino Acid , Viral Proteins/genetics , Viral Proteins/isolation & purificationABSTRACT
The bovine papillomavirus type I transcriptional activator E2 is essential for replication of bovine papillomavirus DNA, yet most of the high-affinity binding sites for E2 are dispensable. Here we demonstrate an absolute requirement for a binding site for the E2 polypeptide as a cis-acting replication element, establishing that site-specific binding of E2 to the origin is a prerequisite for bovine papillomavirus replication in vivo. The position and distance of the E2 binding site relative to the other origin of replication components are flexible, but function at a distance requires high-affinity E2 binding sites. Thus, low-affinity binding sites function only when located close to the origin of replication, while activity at greater distances requires multimerized high-affinity E2 binding sites. The requirement for E2, although different in some respects, shows distinct similarities to what has been termed replication enhancers and may provide insight into the function of this class of DNA replication element.
Subject(s)
Bovine papillomavirus 1/genetics , DNA-Binding Proteins/metabolism , Transcription Factors/genetics , Viral Proteins/metabolism , Virus Replication , Base Sequence , Bovine papillomavirus 1/growth & development , DNA Mutational Analysis , DNA Replication , Enhancer Elements, Genetic/genetics , Molecular Sequence Data , Nucleic Acid Conformation , Structure-Activity Relationship , Transcription, GeneticABSTRACT
Replication of bovine papilloma virus (BPV) DNA requires two virus-encoded proteins, E1 and E2, while all other proteins are supplied by the host cell. Here, we describe the isolation of the E1 protein and show that it is a multifunctional protein. Purified E1 protein was required for the in vitro replication of BPV origin-containing DNA by extracts of mouse cells, as reported [Yang, L., Li, R., Mohr, I. J., Clark, R. & Botchan, M. R. (1991) Nature (London) 353, 628-632]. In addition, the E1 protein cosedimented with a number of other activities including (i) DNA helicase activity, (ii) BPV origin-containing DNA-specific binding activity, (iii) DNA-dependent ATPase activity, and (iv) BPV origin-specific unwinding of superhelical DNA. The E1 protein, acting as a helicase, moved in the 3'-->5' direction, like simian virus 40 (SV40) large tumor antigen, which plays a pivotal role in SV40 DNA replication. However, unlike the SV40 large tumor antigen, the helicase activity of E1 was stimulated 5-fold by the presence of a fork structure at the junction between single-stranded and double-stranded DNA and was supported efficiently by all eight nucleoside triphosphates. The E1-catalyzed ATPase activity required the presence of single-stranded or double-stranded DNAs.
Subject(s)
Bovine papillomavirus 1/growth & development , DNA Replication/drug effects , DNA, Viral/metabolism , DNA-Binding Proteins/pharmacology , Viral Proteins/pharmacology , Adenosine Triphosphatases/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cell Line , Cell-Free System , DNA Helicases/metabolism , DNA-Binding Proteins/isolation & purification , DNA-Binding Proteins/metabolism , Gene Expression , Mice , Molecular Sequence Data , Nucleic Acid Conformation , Viral Proteins/isolation & purification , Viral Proteins/metabolismABSTRACT
Ostensibly comparable mutants of bovine papillomavirus type 1 (BPV-1) affecting the E1 open reading frame that were constructed in several laboratories have been reported to exhibit either reduced or increased transformation efficiencies in established mouse cell lines relative to wild-type BPV-1 DNA. To resolve these discrepancies, we have reexamined many of the mutants in mouse C127 cells by using focus formation assays. Our primary conclusions are that all E1 mutants tested consistently generated reduced numbers of transformants and that the reduced transformation was not due to cell toxicity associated with E1 mutations, as had been proposed. Our results can best be explained by the inability of the E1 mutants to replicate extrachromosomally, therefore leading to a rapid loss of the BPV-1 DNA and consequently, reduced transformation. In support of this hypothesis, we demonstrated that the human papillomavirus type 11 E1 protein was able to suppress BPV-1 transformation, probably because of interference with BPV-1 replication. Therefore, we attribute the phenotypic disparities reported by the various laboratories to still undefined differences in assay conditions.
Subject(s)
Bovine papillomavirus 1/genetics , Cell Transformation, Viral/genetics , DNA-Binding Proteins/genetics , Viral Proteins/genetics , Animals , Bovine papillomavirus 1/growth & development , Cell Line , Genes, Viral/genetics , Mice , Mutation , Viral Interference/genetics , Virus Replication/geneticsABSTRACT
The helper-dependent human parvovirus adeno-associated virus type 2 (AAV) inhibits both the oncogenic transforming abilities and the DNA replication of its helper viruses, adenovirus (Ad), and herpes simplex virus (HSV). As AAV-2 also inhibits the transforming ability of bovine papillomavirus type 1 (BPV), AAV-2 was assayed for its ability to inhibit BPV plasmid DNA replication. Here we find that the AAV-2 Rep78 gene is able to trans-inhibit BPV plasmid DNA replication and that the AAV-2 terminal repeats (TR) are also cis-required for the full inhibitory effect of AAV-2. When both the AAV-2 Rep78 open reading frame and TRs are present the inhibition of BPV plasmid DNA replication is very strong.